Team

Prof. Werner Mohl, MD, PhD

Werner Mohl is the founder of Angel Valve, with more than 40 years of experience in research, patient care and medical education in the cardiovascular field.  He is an inventor and co-inventor of many medtech patents along with the PICSO concept, founding Miracor Medical.  The idea and development of the transcatheter mitral valve repair system, Mitral Butterfly®, is based on his longstanding experience in surgical mitral valve repair.

 

Tamara McIntosh

Tamara McIntosh joined AVVie 2018 as Managing Director in Vienna.  She has previous international management and commercialization experience with JOMDD, CardioVention, CardioThoracic Systems, Cardiogenesis and Merit Medical Systems, along with other startup projects in interventional cardiology and cardiac surgery.  Tamara holds an MSc in Agronomy from University of California, Davis and a BScBA from University of Illinois.

Johanna Ticar

Johanna Ticar joined AVVie in 2017 as the first team member.  She is facilitating the development projects of the Angel Valve product line.  She was previously an R&D engineer at Xeltis in Eindhoven, the Netherlands and has work experience with Siemens Healthcare.  She holds an MSc in Biomedical Engineering from Graz University of Technology and an MSc in Tissue Engineering and Regenerative Medicine from UAS Vienna and has extensive international background.

Olga Górna

Olga Górna joined Angel Valve in 2018 as CAD Engineer.  She graduated from Gdansk University of Technology in Poland and holds
a MSE in Mechanical Engineering and Medical Engineering.  Previously she was with Hansaton in Hamburg.  She has also contributed to a medical device project for the European Institute for Oto-Rhino-Laryngology in Antwerp, Belgium.

Partners

 

 

 

 

PTFE has been established as a medical device material in the cardiovascular sector for many years.

PROFILEN® PTFE yarns from Lenzing Plastics (Lenzing, Austria) have been used by leading manufacturers of artificial heart valves for production.

 

 

LifeTec Group (Eindhoven, The Netherlands) aims to test cardiovascular products via performance assessment in a functional tissue environment, including physiological pressure and flow. LifeTec Group’s cardiac platforms have proven to be an ideal solution for preclinical testing.